113 related articles for article (PubMed ID: 6173362)
1. Further characterization of two "DR supertypic" specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificities.
Tanigaki N; Tosi R; Centis D; Ferrara GB; Pressman D
Hum Immunol; 1981 Oct; 3(2):93-108. PubMed ID: 6173362
[TBL] [Abstract][Full Text] [Related]
2. HLA-DS molecules and their relation to supertypic specificities.
Goyert SM; Moriuchi J; Winchester R; Silver J
Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
[TBL] [Abstract][Full Text] [Related]
3. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
Horibe K; Knowles RW; Dupont B
Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
[TBL] [Abstract][Full Text] [Related]
4. Serological discrimination of DR4 haplotypes by radioimmunoassay.
Tanigaki N; Tosi R; Ferrara GB
Immunogenetics; 1986; 23(1):38-46. PubMed ID: 2417945
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
[TBL] [Abstract][Full Text] [Related]
6. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
Maeda H; Hirata R
J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
[TBL] [Abstract][Full Text] [Related]
7. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a new HLA class II determinant present on cells from HLA-DR1 and/or -DR4 individuals.
Lepage V; Alcalay D; Douay C; Mallet C; Loiseau P; Degos L; Colombani M; Colombani J
Tissue Antigens; 1985 Feb; 25(2):96-102. PubMed ID: 2581334
[TBL] [Abstract][Full Text] [Related]
9. Identification of two cis-encoded HLA-DQ molecules that carry distinct alloantigenic specificities.
Johnson JP; Wank R
J Exp Med; 1984 Nov; 160(5):1350-9. PubMed ID: 6208309
[TBL] [Abstract][Full Text] [Related]
10. HLA-D-DR relationships: PLT studies of HLA-D specificities associated with DR1, DR2, and DR4.
Suciu-Foca N; Godfrey M; Khan R
Hum Immunol; 1981 Jul; 2(4):295-304. PubMed ID: 6168618
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical definition of the new dr specificity 8WDRw13.
Tosi R; Tanigaki N; Centis D; Ferrara GB
Immunol Commun; 1981; 10(3):275-92. PubMed ID: 6174415
[TBL] [Abstract][Full Text] [Related]
12. A new allodeterminant on HLA-DQ molecules carrying the DQw3 specificity.
Tanigaki N; Tosi R; Katagiri M; Ferrara GB
Hum Immunol; 1985 Dec; 14(4):379-90. PubMed ID: 2416721
[TBL] [Abstract][Full Text] [Related]
13. DR5-associated DC molecules carry three different allospecificities.
Tanigaki N; Tosi R; Centis D; Ferrara GB
Hum Immunol; 1985 Jan; 12(1):47-57. PubMed ID: 3871759
[TBL] [Abstract][Full Text] [Related]
14. Purification and separation of subsets of human Ia molecules by papain digestion.
Tanigaki N; Tosi R; Koyama K; Pressman D
Immunology; 1980 Apr; 39(4):615-22. PubMed ID: 6155328
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody detecting an HLA-DQwl-related determinant.
Koning F; Raghoebar J; Schreuder GM; Schuurman R; Bruning H
Tissue Antigens; 1985 Aug; 26(2):100-9. PubMed ID: 2414859
[TBL] [Abstract][Full Text] [Related]
16. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
[TBL] [Abstract][Full Text] [Related]
17. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
18. The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities.
Tanigaki N; Tosi R
Immunol Rev; 1982; 66():5-37. PubMed ID: 6182090
[No Abstract] [Full Text] [Related]
19. Separation of four class II molecules from DR2 and DRw6 homozygous B lymphoid cell lines.
Maeda H; Hirata R
Immunogenetics; 1984; 20(6):639-47. PubMed ID: 6392082
[TBL] [Abstract][Full Text] [Related]
20. The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.
Crepaldi T; Richiardi P; Malavasi F; Carbonara AO; Igarashi M; Ferrone S
Tissue Antigens; 1985 Jul; 26(1):25-34. PubMed ID: 2412306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
